COVID-19 RELATED KIDNEY DAMAGE

NCT ID: NCT04706325

Last Updated: 2021-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-01

Study Completion Date

2021-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, we investigate whether the early detection of risk factors in Covid-19 associated acute kidney injury contributes to us in the early initiation of treatment. We predict that if acute kidney damage is detected early in patients with early risk factors, permanent kidney damage will be seen less. In addition, we think that covid-19 patients may have positive contributions to shortening treatment time and reducing treatment costs. In addition, we are investigating whether it has a positive effect on patients' survival. In other words, we are investigating the contribution of risk factors to early diagnosis and treatment, the effect on health expenditures and mortality in patients with COVID-19 with acute kidney damage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE

COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE

ACUTE KIDNEY INJURY

Intervention Type OTHER

KDIGO LEVELS

COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE

COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE

ACUTE KIDNEY INJURY

Intervention Type OTHER

KDIGO LEVELS

COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.

COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.

ACUTE KIDNEY INJURY

Intervention Type OTHER

KDIGO LEVELS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACUTE KIDNEY INJURY

KDIGO LEVELS

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 aged
* patients in ICU

Exclusion Criteria

* Patients with known Chronic Renal Failure
* who have received dialysis treatment before
* who are under 18 years of age
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kocaeli Derince Education and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aki̇f Şahi̇n

md

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

akif şahin

Role: PRINCIPAL_INVESTIGATOR

kocaeli derh

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Akif Şahin

Kocaeli, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

mehmet yılmaz

Role: CONTACT

05052174432

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

mehmet yılmaz

Role: primary

05052174432

References

Explore related publications, articles, or registry entries linked to this study.

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.

Reference Type RESULT
PMID: 32247631 (View on PubMed)

Aleebrahim-Dehkordi E, Reyhanian A, Saberianpour Sh, Hasanpour-Dehkordi A. Acute kidney injury in COVID-19; a review on current knowledge. J Nephropathol. 2020;9:e31. doi: 10.34172/jnp.2020.31

Reference Type RESULT

Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.

Reference Type RESULT
PMID: 32222812 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

kocaeli derh

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute KIDnEy Injury in CoviD-19
NCT04583293 COMPLETED
Preventing Acute Kidney Injury
NCT04376619 WITHDRAWN NA